1982 Ronald J. Stoney, MD and William K. Ehrenfeld, MD, vascular surgeons at the University of California, San Francisco founded the Pacific Vascular Research Foundation (PVRF) to support vascular surgeons who conducted research to develop innovative treatment strategies.
1990 Vascular Cures expanded its mission to support basic vascular science, focusing on the causes and mechanisms of vascular disease.
1996 The Wylie Scholar Program launched to provide financial research assistance to outstanding surgeon-scientists at the early stage of their careers. Wylie Scholars have become department chairs and leading surgeon-scientists at academic institutions across North America.
2000 The Laboratory for Accelerated Vascular Research (LAVR) was founded at UCSF, a unique collaboration of scientists and physicians to generate new knowledge in vascular biology and device technology. The LAVR was also supported by the Wayne & Gladys Valley Foundation.
2013 Vascular Cures Research Network (VCRN) launches. This collaborative research consortium brought world class investigators together to solve the most urgent problems of patients with vascular disease.
2013 The VCRN launched the Stoney Vascular Biobank, the first national vascular biobank dedicated to collecting tissue samples from thousands of patients with vascular disease.
2014 Vascular Cures hosts the Vascular Innovation Summit bringing together leaders from healthcare systems, academic medical centers, industry, payers, investors and regulators to develop and pursue collaborative projects.
2014 Vascular Cures acquires the digital assets and educational resources of the Vascular Disease Foundation, to provide public education and raise awareness of vascular disease.
2015 Project Voice, a result of the collaborative Vascular Innovation Summit, introduces the first national patient-centered initiative targeting PAD by leveraging the power of digital health.
2016 Vascular Cures held the inaugural Research Summit to identify high priority areas of unmet scientific needs that are suitable for innovative pilot projects with the possibility to have a rapid impact on vascular medicine.
Vascular Cures is at the forefront of vascular research. Our advances include gene therapy to develop new blood vessels, medical devices to avoid major surgery, and human tissue-based grafts to improve outcomes. To learn more about Vascular Cures’ programs click here.